In breast cancer, no difference is found in SOD1 levels between matched plasma and nipple aspirate fluid (NAF) from cancer patients, whereas SOD1 levels in no-cancer NAF are significantly higher compared with matched plasma (37). The gene discussed is SOD1; the disease is cancer.